News and Insights
Evolent addresses a startling difference in what men and women pay for the same drug. Do women really pay more for goods and services simply because of their gender? According to numerous sources, they do. A 2015 study by the New York City Department of …
Our chief medical officer shares three trends likely to impact oncology drug spend in the near future. There's little doubt oncology drug spend will continue to grow at an unsustainable pace, as the drug pipeline pumps out high-priced therapies. But as we …
We are bringing together our businesses and solutions into a unified, rebranded organization that is focused on improving health outcomes for people with complex conditions. By connecting our businesses, which span 5,000 purpose-filled …
How to Talk to Family Members About Hospice and End-of-Life Care …
Through greater use of hypofractionation, Evolent and a health plan partner reduced unnecessary radiation treatments without compromising efficacy for patients with breast cancer. For some breast cancer patients requiring radiation therapy, there's a …
Evolent is leveraging our expertise in two key specialties to reduce cardiovascular damage related to cancer drugs. Cancer patients often face a cruel reality: To treat one disease, they risk developing another one. Cardiotoxicity — the direct damage to …
While many orthopedic procedures can safely be performed outside the hospital, barriers related to implantable devices often stand in the way of the transition. For most patients needing orthopedic surgeries, the ambulatory setting is the best option, …
Appearing on the Health Care Rounds podcast, Evolent Senior Director for Value Transformation Kamal Golla explains why value-based specialty care is primed for growth. About 1 of every 3 patients gets referred by their primary care provider to a …
Prophylactic Mastectomy for Patients With High-Risk Gene Mutations …
Genetic testing in cancer care: Considerations for a condition-based approach …